This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Capsaicin binds the N-terminus of Hsp90, induces lysosomal degradation of Hsp70, and enhances the anti-tumor effects of 17-AAG (Tanespimycin)
Scientific Reports Open Access 23 August 2023
-
Re-examining HSPC1 inhibitors
Cell Stress and Chaperones Open Access 02 March 2017
-
Synthesis, characterization, and pharmacological evaluation of novel azolo- and azinothiazinones containing 2,4-dihydroxyphenyl substituent as anticancer agents
Monatshefte für Chemie - Chemical Monthly Open Access 02 April 2015
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Davenport EL, Moore HE, Dunlop AS, Sharp SY, Workman P, Morgan GJ et al. Heat shock protein inhibition is associated with activation of the unfolded protein response pathway in myeloma plasma cells. Blood 2007; 110: 2641–2649.
Powers MV, Workman P . Inhibitors of the heat shock response: biology and pharmacology. FEBS Lett 2007; 581: 3758–3769.
Mitsiades CS, Mitsiades NS, McMullan CJ, Poulaki V, Kung AL, Davies FE et al. Antimyeloma activity of heat shock protein-90 inhibition. Blood 2006; 107: 1092–1100.
Davenport EL, Morgan GJ, Davies FE . Untangling the unfolded protein response. Cell Cycle 2008; 7: 865–869.
Komarova EY, Afanasyeva EA, Bulatova MM, Cheetham ME, Margulis BA, Guzhova IV . Downstream caspases are novel targets for the antiapoptotic activity of the molecular chaperone hsp70. Cell Stress Chaperones 2004; 9: 265–275.
Powers MV, Clarke PA, Workman P . Dual targeting of HSC70 and HSP72 inhibits HSP90 function and induces tumor-specific apoptosis. Cancer Cell 2008; 14: 250–262.
Evans CG, Chang L, Gestwicki JE . Heat shock protein 70 (Hsp70) as an emerging drug target. J Med Chem 2010; 53: 4585–4602.
Leu JI, Pimkina J, Frank A, Murphy ME, George DL . A small molecule inhibitor of inducible heat shock protein 70. Mol Cell 2009; 36: 15–27.
Powers MV, Jones K, Barillari C, Westwood I, van Montfort RL, Workman P . Targeting HSP70: the second potentially druggable heat shock protein and molecular chaperone? Cell Cycle 2010; 9: 1542–1550.
Acknowledgements
We acknowledge NHS funding to the NIHR Biomedical Research Centre. This work was supported by the Kay Kendall Leukaemia Fund, Myeloma UK, Luck-Hille Foundation, Cancer Research UK Program Grant C309/A8274 and PW is a Cancer Research UK Life Fellow.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors are employees of The Institute of Cancer Research, which has a commercial interest in Hsp90 inhibitors. The authors have been involved in funded research collaborations on Hsp90 inhibitors with Vernalis Ltd. and on chaperone and stress pathways with AstraZeneca. Intellectual property arising from the Hsp90 programme has been licensed to Vernalis and Novartis. PW has been a consultant to Novartis.
Rights and permissions
About this article
Cite this article
Davenport, E., Zeisig, A., Aronson, L. et al. Targeting heat shock protein 72 enhances Hsp90 inhibitor-induced apoptosis in myeloma. Leukemia 24, 1804–1807 (2010). https://doi.org/10.1038/leu.2010.168
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2010.168
This article is cited by
-
Capsaicin binds the N-terminus of Hsp90, induces lysosomal degradation of Hsp70, and enhances the anti-tumor effects of 17-AAG (Tanespimycin)
Scientific Reports (2023)
-
Pharmacological targeting of HSP90 with 17-AAG induces apoptosis of myogenic cells through activation of the intrinsic pathway
Molecular and Cellular Biochemistry (2018)
-
Re-examining HSPC1 inhibitors
Cell Stress and Chaperones (2017)
-
Anti-tumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myeloma
Leukemia (2015)
-
Synthesis, characterization, and pharmacological evaluation of novel azolo- and azinothiazinones containing 2,4-dihydroxyphenyl substituent as anticancer agents
Monatshefte für Chemie - Chemical Monthly (2015)